Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis

Major adjuvant treatments for pancreatic adenocarcinoma include fluorouracil, gemcitabine, chemoradiation, and chemoradiation plus fluorouracil or gemcitabine. Since the optimum regimen remains inconclusive, we aimed to compare these treatments in terms of overall survival after tumour resection and...

Full description

Saved in:

Bibliographic Details
Published in:	The lancet oncology Vol. 14; no. 11; pp. 1095 - 1103
Main Authors:	Liao, Wei-Chih, Chien, Kuo-Liong, Lin, Yu-Lin, Wu, Ming-Shiang, Lin, Jaw-Town, Wang, Hsiu-Po, Tu, Yu-Kang
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.10.2013 Elsevier Limited
Subjects:	Adenocarcinoma - therapy Bias Cancer Chemoradiotherapy, Adjuvant Chemotherapy Hematology Hematology, Oncology and Palliative Medicine Humans Medical prognosis Meta-analysis Oncology Pancreatic Neoplasms - therapy Prognosis Randomized Controlled Trials as Topic Systematic review United Kingdom > UK United States > US
ISSN:	1470-2045, 1474-5488, 1474-5488
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!